Your browser doesn't support javascript.
loading
Effects of oral iron and calcium supplement on the pharmacokinetics and pharmacodynamics of molidustat: an oral HIF-PH inhibitor for the treatment of renal anaemia.
Lentini, Silvia; Kaiser, Andreas; Kapsa, Stefanie; Matsuno, Kumi; van der Mey, Dorina.
Afiliación
  • Lentini S; Clinical Pharmacology Cardiovascular/Haematology, Translational Sciences, Research & Development, Bayer AG, Aprather Weg 18a, 42113, Wuppertal, Germany. silvia.lentini@bayer.com.
  • Kaiser A; Statistics and Data Insights, Data Sciences & Analytics, Research & Development, Bayer AG, Berlin, Germany.
  • Kapsa S; Clinical Pharmacology Cardiovascular/Haematology, Translational Sciences, Research & Development, Bayer AG, Aprather Weg 18a, 42113, Wuppertal, Germany.
  • Matsuno K; Clinical Pharmacology/Clinical Sciences, Research and Development Japan, Bayer Yakuhin Ltd, 4-9, Umeda 2-chome, Kita-ku, Osaka, Japan.
  • van der Mey D; Clinical Pharmacology Cardiovascular/Haematology, Translational Sciences, Research & Development, Bayer AG, Aprather Weg 18a, 42113, Wuppertal, Germany.
Eur J Clin Pharmacol ; 76(2): 185-197, 2020 Feb.
Article en En | MEDLINE | ID: mdl-31919558

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazoles / Triazoles / Calcio / Hierro Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Eur J Clin Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazoles / Triazoles / Calcio / Hierro Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Eur J Clin Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Alemania